Lumexa Imaging Holdings, Inc. (LMRI) vs Tandem Diabetes Care, Inc. (TNDM)
- Lumexa Imaging Holdings, Inc. LMRI 10.64 −1.30%
- Tandem Diabetes Care, Inc. TNDM 16.17 −2.12%
Lumexa Imaging Holdings, Inc. and Tandem Diabetes Care, Inc. are both Medical Devices companies. Tandem Diabetes Care, Inc. is the larger, with a market value of $1.2B against $1.0B — 1.1× the size. Lumexa Imaging Holdings, Inc. has the higher net margin (−2.78% vs −6.08%) and the higher return on invested capital (48.1% vs −10.3%). Across the 16 metrics below, Lumexa Imaging Holdings, Inc. leads on 13 and Tandem Diabetes Care, Inc. on 3.
Valuation
Profitability
| Metric | LMRI | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 63.41% | 56.01% | 56.01% |
| Operating margin | 61.03% | (4.40%) | (15.03%) |
| Net margin | (2.78%) | (6.08%) | (20.40%) |
| Free cash flow margin | 0.83% | (2.56%) | (7.24%) |
| Return on equity | 0.00% | (48.03%) | (15.32%) |
| Return on assets | (5.51%) | (6.24%) | (19.72%) |
| Return on invested capital | 48.10% | (10.33%) | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack